1. Home
  2. OPXS vs CING Comparison

OPXS vs CING Comparison

Compare OPXS & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Optex Systems Holdings Inc.

OPXS

Optex Systems Holdings Inc.

N/A

Current Price

$9.60

Market Cap

70.9M

Sector

Technology

ML Signal

N/A

CING

Cingulate Inc.

HOLD

Current Price

$4.69

Market Cap

70.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPXS
CING
Founded
1987
2012
Country
United States
United States
Employees
72
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
70.2M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
OPXS
CING
Price
$9.60
$4.69
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $21.20
AVG Volume (30 Days)
12.5K
★ 92.6K
Earning Date
08-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
34.55
★ 56.47
EPS
★ 0.41
N/A
Revenue
★ $24,530,000.00
N/A
Revenue This Year
$3.54
N/A
Revenue Next Year
$10.05
N/A
P/E Ratio
$23.66
★ N/A
Revenue Growth
★ 17.63
N/A
52 Week Low
$9.04
$3.16
52 Week High
$17.62
$11.89

Technical Indicators

Market Signals
Indicator
OPXS
CING
Relative Strength Index (RSI) 34.82 44.86
Support Level $9.04 $4.21
Resistance Level $10.85 $5.20
Average True Range (ATR) 0.32 0.25
MACD -0.03 -0.00
Stochastic Oscillator 11.05 61.82

Price Performance

Historical Comparison
OPXS
CING

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson, Applied Optics Center Dallas, and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor, and others.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Share on Social Networks: